The Role of Angiopoietin-2 Gene Mutation on Clinical Severity of Dengue Disease in Children

Authors

  • Mayetti Akmal IDAI
  • Amirah Zatil Izzah
  • Jamsari
  • Eriyati Darwin
  • Dadang Hudaya Somasetia

DOI:

https://doi.org/10.3889/oamjms.2020.5288

Keywords:

Angiopoietin, Dengue, Mutation

Abstract

BACKGROUND: In general, angiopoietin-2 levels are increased concomitantly with dengue clinical severity.

AIM: This research aims to determine the role of mutation on angiopoietin-2 on dengue clinical severity.

METHODS: A cross-sectional study of 108 children with dengue disease grouped by severity. Angiopoietin-2 level was examined by enzyme-linked immunosorbent assay. Polymerase chain reaction and double nucleic acid sequencing are using 2 Exon 4-F primers.

RESULTS: Angiopoietin-2 levels on rs7834131 mutant are higher in dengue fever (p < 0.05) and dengue hemorrhage fever group than non-mutant, while on dengue shock syndrome, it is lower than non-mutant.

CONCLUSION: Angiopoietin-2 mutation on rs7834131 might have a protective effect on dengue disease severity.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Hemorrhagic Fever. Geneva: South East Asia Regional Office, World Health Organization; 2011. https://doi.org/10.1079/9781845939649.0168

Dalrymple NA, Mackow ER. Roles for endothelial cells in dengue virus infection. Adv Virol. 2012;2012:840654. PMid:22952474

Whalen MJ, Doughty LA, Carlos TM, Wisniewski SR, Kochanek PM, Carcillo JA. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med. 2000;28(7):2600-7. https://doi.org/10.1097/00003246-200007000-00070 PMid:10921602

Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006;3(3):e46. https://doi.org/10.1371/journal.pmed.0030046 PMid:16417407

Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell. 2008;14(1):25-36. https://doi.org/10.1016/j.devcel.2007.10.019 PMid:18194650

Rampengan NH, Daud D, Waraouw S, Ganda IJ. Serum angiopoeitin 2 as marker of plasma leakage in dengue viral infection. Am J Clin Exp Med. 2015;3:39-43.

Hawkes M, Rajwans N, Conroy AL, Gélvez M, Tran V, Liles WC, et al. Host biomarkers are associated with progression to dengue haemorrhagic fever: A nested case-control study. Int J Infect Dis. 2015;40:45-53. https://doi.org/10.1016/j.ijid.2015.07.027 PMid:26255888

Mariko R, Darwin E, Yanwirasti Y, Hadinegoro SR. The difference of angiopoietin-2 levels between dengue hemorrhagic fever patients with shock and without shock. Open Access Maced J Med Sci. 2019;7(13):2119-22. https://doi.org/10.3889/oamjms.2019.569 PMid:31456836

Li S, Zhai R, Sheu CC, Gallagher DC, Gong MN, Tejera P, et al. Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med. 2009;35(6):1024- 30. https://doi.org/10.1007/s00134-009-1413-8 PMid:19271210

Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, et al. Haiti: Absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg. 2001;65(3):180-3. https://doi.org/10.4269/ajtmh.2001.65.180 PMid:11561700

Kourí G, Guzmán MG, Valdés L, Carbonel I, del Rosario D, Vazquez S, et al. Reemergence of dengue in Cuba: A 1997 epidemic in Santiago de Cuba. Emerg Infect Dis. 1998;4(1):89-92. https://doi.org/10.3201/eid0401.980111 PMid:9454563

Michels M, Van der Ven AJ, Djamiatun K, Fijnheer R, De Groot PG, Griffioen AW, et al. Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability. Am J Trop Med Hyg. 2012;87(5):943-6. https://doi.org/10.4269/ajtmh.2012.12-0020 PMid:22949515

Van de Weg CA, Pannuti CS, Van den Ham HJ, De Araújo ES, Boas LS, Felix AC, et al. Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection. J Clin Virol. 2014;60(4):328-35. https://doi.org/10.1016/j.jcv.2014.05.001 PMid:24928471

Sumarmo PS. Infeksi virus dengue. In: Sumarmo PS, Garna H, Hadinegoro SR, editors. Buku Ajar Ilmu Kesehatan Anak Dan Penyakit Tropis. 1st ed. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia; 2002. p. 176-208.

Mayetti M. Hubungan gambaran klinis dan laboratorium sebagai faktor risiko syok pada demam berdarah dengue. Sari Pediatr. 2010;11(5):367-77. https://doi.org/10.14238/sp11.5.2010.367-73

Kementerian Kesehatan Republik Indonesia, Laporan Akuntabilitas Kinerja Ditjen PP Dan PL Tahun. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Jakarta: Kementerian Kesehatan Republik Indonesia; 2012. https://doi.org/10.22236/psd/11104-11764

Jessie K, Fong MY, Devi S. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004;189(8):1411-8. https://doi.org/10.1086/383043 PMid:15073678

Ward EG, Grosios K, Markham AF, Jones PF. Genomic structures of the human angiopoietins show polymorphism in angiopoietin-2. Cytogenet Cell Genet. 2001;94(3-4):147-54. https://doi.org/10.1159/000048807 PMid:11856872

Pietrowski D, Tempfer C, Bettendorf H, Bürkle B, Nagele F, Unfried G, et al. Angiopoietin-2 polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril. 2003;80(4):1026- 9. https://doi.org/10.1016/s0015-0282(03)01011-2 PMid:14556828

Onen HL, Konac E, Eroglu M, Ekmekci A. Angiopoeitin-2 gene polymorphism in sporadic prostate cancer. Gazi Med J. 2007;18:121-6.

Harapan H, Fajar JK, Wahyuniati N, Anand JR, Nambaru L, Jamil KF. Non-HLA gene polymorphisms and their implications on dengue virus infection. Egypt J Med Hum Genet. 2003;14(1):1-11. https://doi.org/10.1016/j.ejmhg.2012.08.003

Hubert A, Grimm C, Pietrowski D, Zeillinger R, Bettendorf H, Husslein P, et al. An angiopoietin-2 gene polymorphism in unexplained intrauterine fetal death: A multi-center study. J Reprod Immunol. 2005;65(1):47-53. https://doi.org/10.1016/j.jri.2004.12.001 PMid:15694966

Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A. Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers DNA Cell Biol. 2007;26(7):453-63. https://doi.org/10.1089/dna.2007.0585 PMid:17630849

Lukasz A, Hillgruber C, Oberleithner H, Kusche- Vihrog K, Pavenstädt H, Rovas A. Endothelial glycocalyx breakdown is mediated by angiopoietin-2. Cardiovasc Res. 2017;113(6):671-80. https://doi.org/10.1093/cvr/cvx023 PMid:28453727

Kumpers P, Gueler F, David S, Slyke PV, Dumont DJ, Park JK, et al. The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care Med. 2011;15(5):R261. https://doi.org/10.1186/cc10523 PMid:22040774

Downloads

Published

2020-10-19

How to Cite

1.
Akmal M, Amirah Zatil Izzah, Jamsari, Eriyati Darwin, Dadang Hudaya Somasetia. The Role of Angiopoietin-2 Gene Mutation on Clinical Severity of Dengue Disease in Children. Open Access Maced J Med Sci [Internet]. 2020 Oct. 19 [cited 2024 Apr. 25];8(B):1110-5. Available from: https://oamjms.eu/index.php/mjms/article/view/5288